UBE2Q2: Ubiquitin Conjugating Enzyme E2 Q2
A ubiquitin-conjugating enzyme involved in protein degradation and cellular signaling
Gene Information Card
| Symbol | UBE2Q2 |
|---|---|
| Full Name | Ubiquitin Conjugating Enzyme E2 Q2 |
| Gene Type | Protein coding |
| Chromosomal Location | 15q24.2 |
| NCBI Gene ID | 92912 ncbi.nlm.nih.gov/gene/92912 |
| Ensembl ID | ENSG00000140319 |
| UniProt ID | Q8WVN6 |
| OMIM ID | 617591 |
| HGNC ID | 20087 |
| Aliases | UBE2Q, UBCQ2, UBE2Q2P1 |
Description
UBE2Q2 encodes a member of the ubiquitin-conjugating enzyme (E2) family. This enzyme catalyzes the second step in ubiquitin conjugation, transferring ubiquitin from the E1 complex to a specific E3 ligase, thereby targeting proteins for proteasomal degradation or modifying their function. UBE2Q2 is involved in cell cycle regulation, apoptosis, and response to cellular stress. Dysregulation has been implicated in several cancers and neurodegenerative disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Breast cancer | Overexpression of UBE2Q2 promotes proliferation and inhibits apoptosis via ubiquitination of p53 and other tumor suppressors. | PMID: 25605274 |
| Colorectal cancer | UBE2Q2 upregulation correlates with poor prognosis and enhanced Wnt/β-catenin signaling. | PMID: 29367642 |
| Hepatocellular carcinoma | UBE2Q2 overexpression enhances cell migration and invasion through EMT induction. | PMID: 31034567 |
| Parkinson's disease | UBE2Q2 interacts with parkin and may influence ubiquitination of α-synuclein. | PMID: 21752920 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.5 | Medium |
| Brain | 8.3 | Medium |
| Liver | 6.1 | Low |
| Kidney | 5.4 | Low |
| Heart | 4.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 15.2 | High expression |
| HeLa | 10.8 | Medium expression |
| MCF7 | 9.5 | Medium expression |
| HepG2 | 7.3 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.511C>T (p.Arg171Trp) | Missense | <0.01% | Unknown functional effect |
| c.724G>A (p.Glu242Lys) | Missense | <0.01% | Unknown functional effect |
| c.1003_1004insA | Frameshift | <0.01% | Predicted loss of function |
Mutation functional classification
Loss of Function (LOF)
Frameshift mutations (e.g., c.1003_1004insA) are predicted to cause premature truncation and loss of enzymatic activity.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported.
Dominant Negative (DN)
Not established for UBE2Q2.
View complete mutation data:
Gene Ontology (GO)
| • ubiquitin-protein transferase activity (GO:0004842) | • ubiquitin-dependent protein catabolic process (GO:0006511) |
| • nucleus (GO:0005634) | • cytosol (GO:0005829) |
| • protein ubiquitination (GO:0016567) |
Pathways
• Ubiquitin mediated proteolysis (KEGG: hsa04120)
• Protein processing in endoplasmic reticulum (KEGG: hsa04141)
• p53 signaling pathway (KEGG: hsa04115)
Protein Summary
UBE2Q2 is a 421-amino acid ubiquitin-conjugating enzyme (E2) with a conserved UBC domain. It accepts ubiquitin from the E1 activating enzyme and transfers it to E3 ligases, which then attach ubiquitin to target proteins. UBE2Q2 is widely expressed, with highest levels in testis and brain. It plays roles in cell cycle control, apoptosis, and stress responses. Altered expression is linked to cancer progression and neurodegeneration.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UBE2Q2 Knockout HeLa Cell Line | EDJ-KQ39080 | Human | 92912 | Details Get a Quote |
| UBE2Q2 Knockout HCT 116 Cell Line | EDJ-KQ39079 | Human | 92912 | Details Get a Quote |
| UBE2Q2 Knockout A-549 Cell Line | EDJ-KQ39077 | Human | 92912 | Details Get a Quote |
| UBE2Q2 Knockout HEK293 Cell Line | EDJ-KQ10411 | Human | 92912 | Details Get a Quote |